Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$127.00
Provider: Wright Reports
$403.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Imperva Inc Issues Q1 2012 Guidance; Issues FY 2012 Guidance In Line With Analysts' Estimates


Thursday, 9 Feb 2012 04:05pm EST 

Imperva Inc announced that for first quarter of 2012, it expects revenue for be in the range of $20.5 million to $21.0 million, non-GAAP operating loss to be in the range of $2.8 million to $3.0 million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $2.7 million to $2.9 million, or a loss of $0.12 to $0.13 per share, which excludes stock-based compensation expense. For fiscal 2012, the Company expects revenue to be in the range of $97.0 million to $99.0 million, non-GAAP operating loss to be in the range of $3.3 million to $3.7 million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $2.8 million to $3.2 million, or a loss of $0.12 to $0.14, which excludes stock-based compensation expense. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $97.7 million, operating loss of $3.5 million, net loss of $3.0 and loss per share of $0.13 for fiscal 2012. 

Company Quote

39.29
-0.06 -0.15%
17 May 2013